Ferment 2023 – Tune into the conference!
Watch the Ferment livestream here!
Today, we’re thrilled to be hosting our annual conference, Ferment! The conference brings together stakeholders from across the synthetic biology community, including customers, suppliers, academics, journalists, and many more.
Ferment will begin with a keynote address from Ginkgo co-founder and CEO Jason Kelly, who will discuss the value that outsourcing R&D to a horizontal platform creates for customers across markets, including pharmaceuticals, agriculture, and industrial biotechnology. His presentation will also introduce new services offerings. These services offerings – like Ginkgo Enzyme Services, which was launched in December 2022 – make Ginkgo’s capabilities and biological data assets more accessible to its customers.
Services Overview for Ginkgo R&D Partners
Ginkgo Enzyme Services: Discover, engineer, optimize, and scale up your enzyme. Whether you’re looking for a biocatalyst to replace a chemical synthesis step, looking to improve your enzyme’s function, or aiming to lower your manufacturing costs, Ginkgo’s end-to-end capabilities empower your enzyme R&D.
Ginkgo Microbe Services: Leverage synthetic biology at scale. Whether you’re looking into biological solutions for challenges in agriculture, natural product discovery, microbiome therapeutics, or any other area in which strain optimization can present a bottleneck, Ginkgo can help.
- Learn more about Ginkgo’s strain improvement work at its virtual event here, and about Ginkgo’s offerings in agriculture and its Strain Optimization Services on Ginkgo’s website.
Ginkgo AAV Services: An integrated suite of solutions. The addition of StrideBio’s structure-guided AAV engineering capabilities combined with Ginkgo’s already extensive assets make Ginkgo a unique one-stop shop capable of providing R&D services for gene therapy manufacturing across capsid, payload, and cell line optimization.
- You can learn more by registering for Ginkgo’s upcoming virtual event on May 10.
Ginkgo Cell Therapy Services: Massively parallel testing for a massive design space. Discover and optimize the next-generation of CAR-T for the endpoints that matter to you. Ginkgo’s ultra high throughput mammalian cell engineering foundry is ideally suited to address many outstanding problems in cell therapy, including CAR-T. Ginkgo is actively developing high throughput platforms to enhance CAR potency and specificity by exploring novel construct designs and incorporating synthetic regulatory elements like cell-specific promoters.
- You can learn more about Ginkgo’s ongoing work in this space on Ginkgo’s blog here and here, and you can register for Ginkgo’s virtual event on May 31 here.
Ginkgo RNA Therapeutics Services: The versatility of the RNA modality meets the power and flexibility of Ginkgo’s Foundry. Let the data guide you to the optimal RNA therapeutic for your application. With last year’s acquisition of Circularis, Ginkgo has expanded its platform to screen gene expression regulatory elements in both mRNA and circRNA formats. Partner with Ginkgo to discover sequence elements for improved stability, reduced immunogenicity, improved expression level and cell-type specificity and take advantage of Ginkgo’s end-to-end capabilities to produce your RNA product with high purity.
- Register for Ginkgo’s upcoming virtual event on April 26, and learn more about the company’s work in RNA therapeutics on its website here and here.
Ferment will also feature a range of presentations and panels throughout the day, as well as a special collaboration between Grow by Ginkgo and Pop-Up Magazine, and a reception to close out the day.
- Read the full programming agenda here.
What will you grow with Ginkgo?